Trial Profile
Randomised, single-centre, double-blind study of pazopanib eye drops in healthy subjects.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Wet age-related macular degeneration
- Focus Adverse reactions; Pharmacokinetics
- 27 Nov 2015 New trial record